Algocell

Company Overview

Snapshot

Founded in March 2023 by David Almagor, Omri Schanin, and Eyal Betzalel, Algocell operates with 1–10 employees. The company has raised $2.8M across three funding rounds from three investors. In July 2025, Algocell secured Pre-Seed funding, with Good Company VC participating.

Business overview

Algocell develops solutions for the cell-based industry, focusing on optimizing bio-based product manufacturing. The company's core technology leverages digital twin and Industry 4.0 principles to help businesses balance cost, production volume, and product quality. By minimizing resource use, trial-and-error, and waste, Algocell serves the Health Tech & Life Sciences sector, providing operational optimization solutions through its simulation and imaging capabilities.

Company Intelligence Q&A

What was Algocell's most recent funding activity?

In July 2025, Algocell secured Pre-Seed funding, with Good Company VC participating in the round.

Which investors participated in Algocell's February 2024 funding round?

In February 2024, Algocell received Pre-Seed funding from David Almagor and Raz Alon.

When was Algocell founded and by whom?

Algocell was founded in March 2023 by co-founders David Almagor, Omri Schanin, and Eyal Betzalel.

What is Algocell's primary focus in the market?

Algocell focuses on helping bio-based product companies optimize their operations by balancing cost, production volume, and product quality while minimizing resource use and trial-and-error, utilizing data-driven decisions for the cell-based industry.